News

The bill would allow HHS to reclassify a drug and recoup rebates when a manufacturer deliberately misclassifies a drug.

As Medicare open enrollment for 2019 draws to a close, here are some tips from Morningstar.

A woman's viral social media post about being denied a heart transplant because of funding speaks to something transplant patients know all too well.

As employees put more emphasis on a company's corporate culture, employers are stepping up their efforts.

Medicare for All and Murray-Alexander proposals are part of the conversation, as well as a new Medicare Buy-in proposal.

Choose the legacy retirement plan or go with the new blended plan?